| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
109.27(B) |
| Last
Volume: |
4,233,984 |
Avg
Vol: |
8,368,014 |
| 52
Week Range: |
$48.64 - $77.71 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
421,705 |
996,293 |
2,118,674 |
| Total Sell Value |
$22,679,618 |
$30,048,564 |
$60,765,476 |
$110,963,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
25 |
43 |
79 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Abele John E |
Director |
– • – |
2008-10-09 |
4 |
S |
$8.52 |
$41,687,944 |
D/D |
(4,874,350) |
45,980,274 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-10-09 |
4 |
S |
$8.59 |
$37,705,216 |
I/I |
(4,331,900) |
44,843,285 |
|
- |
|
| Tobin James R |
President & CEO |
• • – |
2008-10-09 |
4 |
OE |
$6.13 |
$2,145,500 |
D/D |
350,000 |
550,000 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-10-08 |
4 |
S |
$8.85 |
$49,214,380 |
I/I |
(5,460,000) |
49,175,185 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-10-08 |
4 |
S |
$8.85 |
$31,394,381 |
D/D |
(3,460,000) |
50,854,624 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-10-07 |
4 |
D |
$10.18 |
$4,072,000 |
I/I |
(400,000) |
0 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2008-07-31 |
4 |
D |
$11.89 |
$12,033 |
D/D |
(1,012) |
6,880 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2008-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,118 |
7,892 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-NeuromodulationOffi |
• – – |
2008-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,774 |
|
- |
|
| Mcconnell William F Jr |
SVP, Administration CRM |
• – – |
2008-07-28 |
4 |
S |
$11.91 |
$238,200 |
D/D |
(20,000) |
43,804 |
|
- |
|
| Groves Ray J |
Director |
– • – |
2008-07-25 |
4 |
B |
$12.23 |
$122,300 |
D/D |
10,000 |
19,167 |
2.39 |
- |
|
| Gilbert James |
EVP |
• – – |
2008-07-24 |
4 |
D |
$12.19 |
$19,419 |
D/D |
(1,593) |
40,323 |
|
- |
|
| Gilbert James |
EVP |
• – – |
2008-07-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,017 |
41,916 |
|
- |
|
| Mcconnell William F Jr |
SVP, Administration CRM |
• – – |
2008-07-24 |
4 |
D |
$12.19 |
$34,022 |
D/D |
(2,791) |
63,804 |
|
- |
|
| Mcconnell William F Jr |
SVP, Administration CRM |
• – – |
2008-07-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,046 |
66,595 |
|
- |
|
| Baim Donald S |
EVP, Chief Med. & Sci. Officer |
• – – |
2008-07-10 |
4 |
D |
$12.23 |
$64,721 |
D/D |
(5,292) |
29,421 |
|
- |
|
| Baim Donald S |
EVP, Chief Med. & Sci. Officer |
• – – |
2008-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,666 |
34,713 |
|
- |
|
| Laviolette Paul A |
COO |
• – – |
2008-07-01 |
4 |
D |
$12.19 |
$77,407 |
D/D |
(6,350) |
63,072 |
|
- |
|
| Laviolette Paul A |
COO |
• – – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
69,422 |
|
- |
|
| Burns Ursula M |
Director |
– • – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
17,500 |
|
- |
|
| Pucel Kenneth |
EVP, Operations |
• – – |
2008-07-01 |
4 |
D |
$12.19 |
$30,963 |
D/D |
(2,540) |
22,201 |
|
- |
|
| Pucel Kenneth |
EVP, Operations |
• – – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
24,741 |
|
- |
|
| Moreci Stephen F |
Sr. VP, Endosurgery |
• – – |
2008-07-01 |
4 |
D |
$12.19 |
$30,963 |
D/D |
(2,540) |
11,815 |
|
- |
|
| Moreci Stephen F |
Sr. VP, Endosurgery |
• – – |
2008-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
14,355 |
|
- |
|
| Burns Brian R |
SVP - Quality |
• – – |
2008-07-01 |
4 |
D |
$12.19 |
$30,963 |
D/D |
(2,540) |
14,119 |
|
- |
|
2009 Records found
|
|
Page 72 of 81 |
|
|
0.60 (0.78%) 
